{"title":"基于停留时间约束的次优切换控制病毒突变","authors":"E. Hernández-Vargas, P. Colaneri, R. Middleton","doi":"10.1109/CDC.2012.6426559","DOIUrl":null,"url":null,"abstract":"Regulation of mutant viri is important in many disease including HIV infection. Under current multi-drug Anti-Retroviral Therapies for HIV treatment, resistant mutations and failure to regulate viral load is typically observed after approximately 6 years. When this occurs, the current therapy must be abandoned and a new therapy initiated. An alternate approach is to treat this as a switching control problem, wherein therapy may be alternated well before virological failure is observed. In this paper we extend previous work on suboptimal control of a simplified model of HIV infection with mutations. The particular extension here is to include a `dwell time' constraint on the switching actions, that is, impose a strict minimum time between altering therapy.","PeriodicalId":312426,"journal":{"name":"2012 IEEE 51st IEEE Conference on Decision and Control (CDC)","volume":"2012 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":"{\"title\":\"Sub-optimal switching with dwell time constraints for control of viral mutation\",\"authors\":\"E. Hernández-Vargas, P. Colaneri, R. Middleton\",\"doi\":\"10.1109/CDC.2012.6426559\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Regulation of mutant viri is important in many disease including HIV infection. Under current multi-drug Anti-Retroviral Therapies for HIV treatment, resistant mutations and failure to regulate viral load is typically observed after approximately 6 years. When this occurs, the current therapy must be abandoned and a new therapy initiated. An alternate approach is to treat this as a switching control problem, wherein therapy may be alternated well before virological failure is observed. In this paper we extend previous work on suboptimal control of a simplified model of HIV infection with mutations. The particular extension here is to include a `dwell time' constraint on the switching actions, that is, impose a strict minimum time between altering therapy.\",\"PeriodicalId\":312426,\"journal\":{\"name\":\"2012 IEEE 51st IEEE Conference on Decision and Control (CDC)\",\"volume\":\"2012 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-12-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2012 IEEE 51st IEEE Conference on Decision and Control (CDC)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/CDC.2012.6426559\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2012 IEEE 51st IEEE Conference on Decision and Control (CDC)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/CDC.2012.6426559","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Sub-optimal switching with dwell time constraints for control of viral mutation
Regulation of mutant viri is important in many disease including HIV infection. Under current multi-drug Anti-Retroviral Therapies for HIV treatment, resistant mutations and failure to regulate viral load is typically observed after approximately 6 years. When this occurs, the current therapy must be abandoned and a new therapy initiated. An alternate approach is to treat this as a switching control problem, wherein therapy may be alternated well before virological failure is observed. In this paper we extend previous work on suboptimal control of a simplified model of HIV infection with mutations. The particular extension here is to include a `dwell time' constraint on the switching actions, that is, impose a strict minimum time between altering therapy.